Dow Up 0.08% Nasdaq Down 0.30%

Agios Pharmaceuticals, Inc. (AGIO)

-NasdaqGS
48.91 Up 0.28(0.58%) Sep 19, 4:00PM EDT
|After Hours : 48.91 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:48.63
Open:49.00
Bid:48.06 x 500
Ask:55.10 x 100
1y Target Est:59.25
Beta:1.979
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:48.50 - 50.98
52wk Range:15.77 - 50.98
Volume:1,700,871
Avg Vol (3m):388,453
Market Cap:1.69B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AGIO

Comparison

Symbol% ChgMkt Cap
AGIOUp 0.58%1.69B
ALXNDown 0.07%31.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.94
Quarterly EPS Est (Sep-14) :-0.53
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback